1. Inicio
  2. Publicaciones
  3. Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations.

Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Cordoba Largo S
  • Rodriguez, Isabel Rodriguez
  • Rodriguez Villalba S
  • Najjari Jamal D
  • Anchuelo Latorre J
  • Garcia Cabezas S
  • de la Fuente Alonso C
  • Couselo Paniagua L
  • Martínez Montesinos I
  • Villafranca Iturre E
  • Belinchón Olmeda B
  • Farga Albiol D
  • Navarrete Solano PA
  • Sánchez Belda M
  • GINECOR (Spanish Gynaecological Tumors Group of SEOR)

Grupos

Abstract

PURPOSE: The present consensus statement was developed by the GINECOR working group on behalf of the Spanish Society of Radiation Oncology (SEOR). Given the lack of prospective data on the management of vulvar carcinoma, this document provides an up-to-date review of radiotherapy treatment in vulvar cancer and a series of consensus-based recommendations from a group of experts. METHODS: A two-round, online modified Delphi study was conducted to reach consensus treatment recommendations in three clinical settings: 1) adjuvant treatment, 2) locally-advanced vulvar cancer (LAVC), and 3) recurrent disease. After the first round, we comprehensively reviewed the available medical literature from peer-reviewed journals to assess and define the evidence-based treatment options. In the second round, participants were asked to indicate their level of agreement with the preliminary recommendations according to the GRADE (Grade of Recommendation, Assessment, Development, and Evaluation) criteria, as follows: strongly agree; agree; neither agree nor disagree; disagree; strongly disagree. RESULTS: The main recommendations were as follows: 1) following surgical resection, adjuvant radiotherapy is recommended with the presence of adverse risk factors (primarily positive margins and lymph node involvement); 2) radiotherapy (with or without chemotherapy) should be considered in LAVC; and 3) in recurrent disease, radiotherapy should be individualised on a case-by-case basis. A high level of agreement over 80% was reached. CONCLUSIONS: In the absence of robust clinical data, these final recommendations may help to select the optimal radiotherapy approach for this relatively rare cancer.

© 2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Datos de la publicación

ISSN/ISSNe:
1699-048X, 1699-3055

Clinical & Translational Oncology  SPRINGER INT PUBL AG

Tipo:
Article
Páginas:
2153-2168
PubMed:
36961727
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,764 SCImago ℠
Cuartil:
Q2 SCImago ℠

Citas Recibidas en Web of Science: 5

Citas Recibidas en Scopus: 4

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Brachytherapy; Chemoradiation; Radiation therapy; Surgery; Vulvar cancer

Campos de Estudio

Compartir